Where does Paradromics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Paradromics, Inc. ranks #32,804 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Paradromics, Inc. hold?

Paradromics, Inc. holds 8 US utility patents granted between 2019 and 2024, spanning 10 technology areas.

What is Paradromics, Inc.'s Innovation Score?

Paradromics, Inc. has an Innovation Score of 37.3 out of 100 (top 44% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Paradromics, Inc. focus on?

Paradromics, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 6 patents. Grants appear in 10 CPC subclasses total.

Is Paradromics, Inc.'s patent grant rate increasing or decreasing?

Paradromics, Inc.'s recent grant velocity is +600% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Paradromics, Inc.'s patents?

Paradromics, Inc.'s patents average 19.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Paradromics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Paradromics, Inc.

USPTO PatentsView assignee record - 8 granted patents across 10 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Paradromics ranks #32,804 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 10 technology areas.

#32,804
of 49,997 US assignees by volume: Top 44%
by Innovation Score (37.3/100): 19.8
avg claims per patent: +600%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R32804 · US Corporation #32,804 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #32,804/49,997
PHOTO-FINISH Pacific Cycle
CPC-FOCUS A61B · 10 areas
INNOV-THIN 37.3/100
CLAIMS-RICH 19.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +600% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Pacific Cycle, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Airspan Networks · near

37
Asana BioSciences · near

37
Kuroda Precision… · near

37
Paradromics · this assignee

37
Pfenex · near

37
3D Lighting… · lowest

7

What this shows Paradromics's Innovation Score is 37.3/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Paradromics's grants concentrate

Paradromics, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 75% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2019. By volume, Paradromics sits between Pacific Cycle, LLC and Peacs Investments B.V..

Paradromics's three-year grant acceleration

Paradromics, Inc. shows 4 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Pacific Cycle

8
Palm Coast Imports

8
Panjiva

8
Parabellum Strate…

8
Parker Maritime

8
Pastoral Greenhou…

8
Pathologica

8
Peacs Investments…

8
Paradromics ◀

8

What this shows Paradromics holds 8 patents at rank #32,865, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Paradromics

By rank, the assignees closest to #32,865 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Paradromics's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Paradromics, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Pfenex Inc. 37 Airspan Networks Inc. 37 Kuroda Precision Industries Ltd. 37 Asana BioSciences, LLC 37

Paradromics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Paradromics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	12.5%
2020	2	25.0%
2021	1	12.5%
2022	1	12.5%
2024	3	37.5%

Which technologies does Paradromics, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 6

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

C25D - Processes FOR THE Electrolytic OR Electrophoretic Production OF COATINGS; ELECTROFORMING; Apparatus Therefor 1

Y10T - Technical Subjects Covered BY Former US Classification 1

H03F - Amplifiers 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 1

H01L - Semiconductor Devices NOT Covered BY Class H10 1

C23C - Coating Metallic MATERIAL; Coating Material With Metallic MATERIAL; Surface Treatment OF Metallic Material BY Diffusion Into THE Surface, BY Chemical Conversion OR SUBSTITUTION; Coating BY Vacuum Evaporation, BY Sputtering, BY ION Implantation OR BY Chemical Vapour Deposition, IN General 1

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#32,804

of 49,997 tracked assignees

Innovation Score

37.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Paradromics, Inc.'s patent record in context - here's where to go next.

Paradromics, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 75% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #32,804 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Paradromics, Inc. against Pacific Cycle, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.